Oral health condition in cancer patients under bisphosphonate therapy

被引:5
|
作者
Caldas, Rogerio Jardim [1 ,2 ]
Antunes, Heliton Spindola [3 ]
Rodini Pegoraro, Camila de Oliveira [4 ]
Guedes, Fabio Ribeiro [5 ]
da Silva Santos, Paulo Sergio [2 ]
机构
[1] Mario Kroeff Hosp, Dept Dent, Rio De Janeiro, Brazil
[2] Univ Sao Paulo, Bauru Sch Med, Dept Surg Stomatol Pathol & Radiol, Alameda Dr Octavio Pinheiro Brisolla 9-75, BR-17012901 Bauru, SP, Brazil
[3] Natl Inst Canc, Div Clin Res & Technol Dev, Rio De Janeiro, Brazil
[4] Univ Sao Paulo, Bauru Sch Dent, Dept Biol Sci, Bauru, SP, Brazil
[5] Univ Fed Rio de Janeiro, Fac Dent, Dept Pathol & Oral Diag, Rio De Janeiro, Brazil
关键词
Caries; Periodontal disease(s); periodontitis; Oral hygiene; Osteonecrosis; Oncology; Epidemiology; MEDICATION-RELATED OSTEONECROSIS; RISK-FACTORS; MULTIPLE-MYELOMA; ZOLEDRONIC ACID; PROSTATE-CANCER; JAW; ASSOCIATION; DENOSUMAB; BREAST;
D O I
10.1007/s00520-021-06362-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives To investigate the association of oral health condition with the occurrence of medication-related osteonecrosis of the jaw (MRONJ) in a cancer population. Methods A multicenter cross-sectional study was conducted with cancer patients exposed to bisphosphonates for at least 7 months. Dental and periodontal conditions were assessed by epidemiological indices. Results The sample consisted of 80 patients under bisphosphonate therapy, nine of which were allocated to group 1 (with MRONJ) and 71 to group 2 (without MRONJ). Osteonecrosis cases presented 19 decayed, missing, and filled teeth on average. Moderate gingival inflammation was noted in both groups and together with severe inflammation exceeded 50% of the groups. The presence of dental calculus was detected in about half of the individuals in both groups. Shallow periodontal pockets were detected in about 25% of both groups. Deep periodontal pockets were more prevalent among patients with osteonecrosis. Regular oral hygiene was detected in approximately 25% of individuals in both groups. There was a strong positive correlation between the clinical staging of osteonecrosis and decayed, missing, and filled teeth index (DMFTI). Conclusions Patients had a poor oral health condition. All but one osteonecrosis case had no previous history of tooth extraction; oral infections seemed to play a major role in the development of bone necrosis. Advanced osteonecrosis stages were associated with a higher DMFTI.
引用
收藏
页码:7687 / 7694
页数:8
相关论文
共 50 条
  • [1] Oral health condition in cancer patients under bisphosphonate therapy
    Rogério Jardim Caldas
    Héliton Spíndola Antunes
    Camila de Oliveira Rodini Pegoraro
    Fábio Ribeiro Guedes
    Paulo Sérgio da Silva Santos
    Supportive Care in Cancer, 2021, 29 : 7687 - 7694
  • [2] Impact of Bisphosphonate Therapy on Oral Health in Patients with Breast and Prostate Cancer and Bone Metastases: A Comprehensive Study
    Calik, Jacek
    Calik, Katarzyna
    Sauer, Natalia
    Zdzislaw, Bogucki
    Giedziun, Piotr
    Mackiewicz, Jacek
    Murawski, Marek
    Dziegiel, Piotr
    CANCERS, 2024, 16 (06)
  • [3] Oral health status and radiographic findings in pediatric patients undergoing bisphosphonate therapy
    Mikulec, R. T.
    da Fonseca, M.
    Mahan, J.
    BONE, 2007, 40 (06) : S65 - S66
  • [4] Oral Health Considerations in Older Women Receiving Oral Bisphosphonate Therapy
    Lo, Joan C.
    O'Ryan, Felice
    Yang, Jingrong
    Hararah, Mohammad K.
    Gonzalez, Joel R.
    Gordon, Nancy
    Silver, Paula
    Ansfield, Alice
    Wang, Benjamin
    Go, Alan S.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2011, 59 (05) : 916 - 922
  • [5] Bisphosphonate Therapy for Patients with Breast Cancer
    Lipton, Allan
    CURRENT CANCER THERAPY REVIEWS, 2005, 1 (03) : 217 - 225
  • [6] Oral health and health behavior in patients under anticoagulation therapy
    Padrón, N
    Limeres, J
    Tomás, I
    Dios, PD
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 2003, 96 (05): : 519 - 520
  • [7] Gastrointestinal side effects can reduce compliance with oral bisphosphonate therapy in cancer patients
    Heatley, S.
    Lothman, H.
    Major, P.
    EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2006, 10 (03) : 226 - 226
  • [8] Fewer Deaths in elderly Patients on oral Bisphosphonate Therapy
    Pfeilschifter, Johannes
    OSTEOLOGIE, 2010, 19 (04) : 366 - 366
  • [9] Decreased risk of breast cancer associated with oral bisphosphonate therapy
    Mathew, Aju
    Brufsky, Adam
    BREAST CANCER-TARGETS AND THERAPY, 2012, 4 : 75 - 81
  • [10] An oral complication of bisphosphonate therapy
    Khanna, Sagar
    Prendes, Brandon
    BMJ-BRITISH MEDICAL JOURNAL, 2024, 386